BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Based Blood Collection Platform for Remote Monitoring in Rheumatoid Arthritis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Ulster

About this trial

The BloodTrackR Usability and Concordance Study (BUCS) is evaluating a novel home-based blood collection device and companion mobile application for people with rheumatoid arthritis. Participants will use the BloodTrackR device to collect a finger-prick blood sample at home and complete symptom assessments through the app.

The study will assess how easy the device and app are to use, whether participants can successfully collect high-quality blood samples outside of a healthcare setting, and how closely the results compare with standard venous blood samples collected by a phlebotomist. Findings will help determine the potential of BloodTrackR to support remote monitoring and reduce reliance on NHS phlebotomy services.

Eligibility criteria

Qualifiers

Individuals living with rheumatoid arthritis, who attend community groups or rheumatoid arthritis charity groups

Aged 18 years or older

Able to understand written and spoken English

Individuals who have the capacity to consent

Disqualifiers

Participants <18years

Participants taking antibiotics/antivirals

No access to WiFi or a smartphone/tablet

Trial design

Treatments tested in this trial

  • BloodTrackR - Home Blood Collection Platform

Treatment groups

20 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Ulster

Lead sponsor

National Institute for Health Research, United Kingdom

Collaborator